However, the randomized control trial on the effectiveness of t-PA for 233 cardiac arrest patients with pulseless electric activities demonstrated fibrinolysis therapy did not improve the percentage of ROSC or clinical outcomes [5]. This evidence concerns the gene PLAT and cardiac arrest.